Business Context and Reporting Period
This Form 6-K filing by CollPlant Biotechnologies Ltd. is dated November 26, 2025. The report serves to notify shareholders of an upcoming Annual and Extraordinary General Meeting scheduled for December 31, 2025, in Tel-Aviv, Israel. The filing incorporates the Notice and Proxy Statement and a Proxy Card for shareholder voting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The document focuses solely on corporate governance procedures for the upcoming meeting.
Guidance, Outlook, and Risks
Management commentary, financial guidance, outlook, risks, contingencies, and unusual items are not addressed in this specific filing. The content is limited to the logistics of the General Meeting and the attached voting materials.
Investor Verification Checklist
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the voting procedures and deadlines for the December 31, 2025, General Meeting.
- Review the most recent Form 20-F or quarterly reports for actual financial performance data, as this filing contains none.